Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why Motus GI Holdings Shares Are Getting Hammered Today

Motus GI Holdings Inc (NASDAQ: MOTS) shares are trading lower by 17.10% to $0.22 during Monday's trading session after the company announced a 1-for-20 reverse stock split. What Happened?
byHenry Khederian
July 25, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Motus GI Holdings Inc (NASDAQ:MOTS) shares are trading lower by 17.10% to $0.22 during Monday’s trading session after the company announced a 1-for-20 reverse stock split.

What Happened?

Motus GI Holdings says the reverse stock split is intended to increase the per share trading price of Motus GI’s common stock to satisfy the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market (Rule 5550(a)(2)).

The company’s common stock will begin trading on a split-adjusted basis at the opening of the market on Tuesday, July 26.

See Also: Why Bitcoin- And Ethereum-Related Stocks MicroStrategy And Coinbase Are Diving

Motus GI Holdings is a medical technology company.

According to data from Benzinga Pro, Motus GI Holdings has a 52-week high of $1.01 and a 52-week low of $0.22.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

EXCLUSIVE: Coya Therapeutics, Focused On Neurodegenerative Diseases Has Gained 70% Since IPO; CEO Highlights Efforts On Combination Therapy For Rare Diseases

By Vandana Singh
May 27, 9:43 AM
Coya Therapeutics is working On neurodegenerative disease treatment with its combination therapies targeting regulatory T cells. CEO Howard Berman discusses the potential of COYA 302 for ALS, FTD, Parkinson's, and Alzheimer's, emphasizing a transformative approach to immune balance restoration.

BBIB